Literature DB >> 26514660

Characterization of dendritic cells in lip and oral cavity squamous cell carcinoma.

Nádia Lago Costa1, Andréia Souza Gonçalves1, Allisson Filipe Lopes Martins1, Diego Antônio Costa Arantes1, Tarcília Aparecida Silva2, Aline Carvalho Batista1.   

Abstract

BACKGROUND: There may be differences in the antitumor immunity induced by dendritic cells (DCs) during the development of squamous cell carcinoma (SCC) located in the lip rather than in the oral cavity. The aim of this study was to evaluate the number of immature and mature DCs in SCC and potentially malignant disorders of the oral cavity and lip.
METHODS: Immunohistochemistry was used to identify the number (cells/mm(2) ) of immature (CD1a(+) ) or mature (CD83(+) ) DCs in samples of oral cavity SCC (OCSCC) (n = 39), lip SCC (LSCC) (n = 23), leukoplakia (LK) (n = 21), actinic cheilitis (AC) (n = 13), and normal mucosa of the oral cavity (OC control, n = 12) and the lip (lip control, n = 11).
RESULTS: The number of CD1a(+) cells tended to be higher in the OC control samples compared with the LK (P = 0.04) and OCSCC (P = 0.21). Unlike, this cell population was lower in the lip control than in AC or LSCC (P < 0.05). The number of CD83(+) cells was increased in the LSCC samples compared with the AC and lip control (P = 0.0001) and in OCSCC compared with both the LK (P = 0.001) and OC control (P = 0.0001) samples. LSCC showed an elevated number of CD1a(+) and CD83(+) cells compared with OCSCC (P = 0.03). The population of mature DCs was lower than the population of immature DCs in all of the tested groups (P < 0.05).
CONCLUSION: There were a greater number of both mature and immature DC populations in the LSCC samples than in the OCSCC, which could contribute to establishing a more effective immune antitumor response for this neoplasm.
© 2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  dendritic cell; lip cancer; oral cancer; potentially malignant disorders; squamous cell carcinoma

Mesh:

Substances:

Year:  2015        PMID: 26514660     DOI: 10.1111/jop.12380

Source DB:  PubMed          Journal:  J Oral Pathol Med        ISSN: 0904-2512            Impact factor:   4.253


  6 in total

1.  Decreased CD1a + and CD83 + cells in tonsillar squamous cell carcinoma regardless of HPV status.

Authors:  Ana Guadalupe Gama-Cuellar; Ana Lúcia Noronha Francisco; João Figueira Scarini; Fernanda Viviane Mariano; Luiz Paulo Kowalski; Rogério Gondak
Journal:  J Appl Oral Sci       Date:  2022-05-16       Impact factor: 3.144

2.  Genetic Cross-Talk between Oral Squamous Cell Carcinoma and Type 2 Diabetes: The Potential Role of Immunity.

Authors:  Yunjian Fan; Jie Zhang; Jiayu Shi; Lin Chen; Jiazhen Long; Shuqi Zhang; Shuguang Liu
Journal:  Dis Markers       Date:  2022-05-19       Impact factor: 3.464

Review 3.  Activities of stromal and immune cells in HPV-related cancers.

Authors:  Marconi Rego Barros; Cristiane Moutinho Lagos de Melo; Maria Luiza Carneiro Moura Gonçalves Rego Barros; Rita de Cássia Pereira de Lima; Antonio Carlos de Freitas; Aldo Venuti
Journal:  J Exp Clin Cancer Res       Date:  2018-07-05

4.  Impact of HPV Infection on the Immune System in Oropharyngeal and Non-Oropharyngeal Squamous Cell Carcinoma: A Systematic Review.

Authors:  Jerome R Lechien; Imelda Seminerio; Géraldine Descamps; Quentin Mat; Francois Mouawad; Stéphane Hans; Morbize Julieron; Didier Dequanter; Thibault Vanderhaegen; Fabrice Journe; Sven Saussez
Journal:  Cells       Date:  2019-09-10       Impact factor: 6.600

5.  CD1a+ and CD207+ cells are reduced in oral submucous fibrosis and oral squamous cell carcinoma.

Authors:  L-C Silva; F-P Fonseca; O-P Almeida; B-A Mariz; M-A Lopes; R Radhakrishnan; M Sharma; L-P Kowalski; P-A Vargas
Journal:  Med Oral Patol Oral Cir Bucal       Date:  2020-01-01

6.  Hyperion imaging system reveals heterogeneous tumor microenvironment of oral squamous cell carcinoma patients at T1N0M0 stage.

Authors:  Shang Xie; Xiao-Feng Shan; Vicky Yau; Jian-Yun Zhang; Xin-Yuan Zhang; Yong-Pan Yan; Zhi-Gang Cai
Journal:  Ann Transl Med       Date:  2020-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.